8.1 Modes of PAP Therapy: CPAP, APAP, BiPAP & ASV

8.1 Modes of PAP Therapy: CPAP, APAP, BiPAP & ASV

Quick Answer: Positive Airway Pressure (PAP) delivers pressurized air to maintain upper airway patency during sleep. Modalities range from fixed Continuous Positive Airway Pressure (CPAP, 4–20 cmH2O), the gold standard for uncomplicated obstructive sleep apnea (OSA), to auto-adjusting PAP (APAP) that tracks airflow limitation. Bilevel PAP (BiPAP) separates Inspiratory Positive Airway Pressure (IPAP) and Expiratory Positive Airway Pressure (EPAP) to generate Pressure Support (PS = IPAP - EPAP), which augments tidal volume and unloads ventilatory muscles in hypoventilation syndromes and COPD overlap. Adaptive Servo-Ventilation (ASV) uses dynamic servomechanisms to target ~90% of recent minute ventilation for central sleep apnea and Cheyne-Stokes breathing, but needs specialist review in symptomatic heart failure with reduced ejection fraction (LVEF ≤45%) and predominant central apnea because of the mortality signal in the SERVE-HF trial.

Positive airway pressure (PAP) therapy is the cornerstone of medical management for sleep-related breathing disorders. For the Clinical Sleep Health Specialist (CCSH), understanding the precise biomechanical mechanisms, pneumatic characteristics, device algorithms, and clinical parameters of each PAP modality is necessary to guide clinical titrations, resolve therapy intolerance, and safeguard patient safety.

Continuous Positive Airway Pressure (CPAP)

Continuous Positive Airway Pressure (CPAP) delivers a single, continuous, fixed column of positive pneumatic pressure throughout both inspiration and expiration across the entire nocturnal sleep period. Standard clinical CPAP devices operate across an adjustable therapeutic pressure range of 4 to 20 cmH2O.

The Pneumatic Splint Mechanism

The primary biomechanical mechanism of CPAP is pneumatic splinting of the collapsible pharyngeal airway. In patients with OSA, sleep-induced loss of pharyngeal dilator muscle tone (such as the genioglossus, tensor veli palatini, and hyoglossus) combined with anatomical narrowing results in subatmospheric luminal pressures during inspiration, triggering repetitive pharyngeal collapse. CPAP increases intraluminal pressure above critical closing pressure (Pcrit), effectively pushing the soft palate, tongue base, and lateral pharyngeal walls outward.

Cardiorespiratory Physiological Effects

Beyond upper airway stabilization, CPAP exerts profound downstream cardiopulmonary effects:

• Increases Functional Residual Capacity (FRC): By preventing end-expiratory alveolar collapse (atelectasis), CPAP expands end-expiratory lung volume, improving ventilation-perfusion matching and nocturnal oxygenation.
• Reduces Left Ventricular Afterload: In healthy individuals or hypervolemic patients, positive intrathoracic pressure reduces left ventricular transmural pressure (systolic cavity pressure minus pleural pressure), decreasing cardiac workload.
• Dampens Sympathetic Tone: By eliminating obstructive apneas, intermittent nocturnal hypoxemia, and hypercapnic surges, CPAP suppresses excessive nocturnal autonomic sympathetic nervous system outflow, lowering systemic arterial blood pressure.

Despite its status as the gold-standard first-line treatment for OSA, patient adherence is often challenged by the sensation of exhaling against a continuous high pneumatic column (typically when pressures exceed 12 to 15 cmH2O).

AASM 2019 PAP Guideline Highlights

The AASM's 2019 clinical practice guideline on PAP for adult OSA:

• Recommends PAP for OSA with excessive sleepiness (strong), and suggests it for OSA with impaired sleep-related quality of life or comorbid hypertension.
• Recommends starting PAP either with home APAP or with in-lab titration in adults without significant comorbidities, and using CPAP or APAP for ongoing treatment.
• Recommends educational interventions when PAP starts, and suggests behavioral and troubleshooting interventions and telemonitoring-guided interventions during the first weeks to improve adherence.

Auto-Adjusting Positive Airway Pressure (APAP)

Auto-adjusting Positive Airway Pressure (APAP) incorporates onboard microprocessor pressure and pneumotachograph flow sensors running proprietary automated titration algorithms. Instead of a single fixed pressure, the prescribing clinician establishes a minimum pressure (APAP min) and a maximum pressure (APAP max)—for example, 6 to 14 cmH2O.

Algorithmic Sensing and Pressure Escalation

APAP algorithms continuously evaluate inspiratory flow-volume contours on a breath-by-breath basis. The device detects upper airway instability across a hierarchical continuum:

1. Inspiratory Flow Limitation: Early partial airway narrowing causes flattening of the inspiratory flow contour (loss of the smooth sinusoidal wave). APAP algorithms interpret flattening as an early warning sign and incrementally raise pressure by 0.5 to 1.0 cmH2O over several breaths.
2. Vibratory Snoring: High-frequency acoustic or flow oscillations indicate tissue vibration preceding collapse. Algorithms respond with swift pressure increases.
3. Obstructive Hypopneas and Apneas: Cessation or marked reduction in airflow triggers pressure escalation until normal airflow is restored.

Clinical Benefits & Limitations

APAP is particularly advantageous for patients with variable pressure requirements throughout the night, such as:

• Positional OSA: Patients requiring low pressures (e.g., 6–8 cmH2O) while in the lateral decubitus position, but elevated pressures (e.g., 12–15 cmH2O) when supine.
• REM-Dependent OSA: Patients exhibiting profound pharyngeal collapse exclusively during REM atonia.
• Variable Airway Resistance: Night-to-night fluctuations secondary to seasonal rhinitis, alcohol consumption, or sedative medications.

Bilevel Positive Airway Pressure (BiPAP / BPAP)

Bilevel Positive Airway Pressure delivers two distinct, independently adjustable pressure levels during the respiratory cycle:

• Inspiratory Positive Airway Pressure (IPAP): The elevated pneumatic pressure delivered during patient inspiration.
• Expiratory Positive Airway Pressure (EPAP): The baseline pneumatic pressure delivered during patient expiration.

Pressure Support (PS) Mechanics

The difference between IPAP and EPAP is defined as Pressure Support (PS):

$\text{Pressure Support (PS)} = \text{IPAP} - \text{EPAP}$

Understanding the distinct physiological functions of EPAP and IPAP is fundamental for the CCSH specialist:

• EPAP Functions as the Pneumatic Splint: EPAP prevents end-expiratory upper airway collapse and eliminates obstructive apneas. In titration, obstructive apneas are treated by raising EPAP, together with IPAP so that pressure support is maintained.
• IPAP and Pressure Support Drive Alveolar Ventilation: IPAP expands the pharyngeal lumen during inspiration, resolves inspiratory flow limitation, eliminates snoring, and clears hypopneas. Crucially, the mathematical spread of Pressure Support (PS) directly determines tidal volume ($V_T$) augmentation, unloading respiratory musculature and washing out carbon dioxide ($CO_2$).

Airway Pressure Profile:

Pressure (cmH2O)
  ^
  |         +---------------+                 +---------------+
  |  IPAP   |  Inspiration  |                 |  Inspiration  |
  |  (16)   |  (Tidal Vol)  |                 |  (Tidal Vol)  |
  |         |               |                 |               |
  |         |     PS = 6    |                 |     PS = 6    |
  |         +---------------+                 +---------------+
  |  EPAP   |               |  +-----------+  |               |  +-----------+
  |  (10)   |               |  |Expiration |  |               |  |Expiration |
  |         |               |  |(Splinting)|  |               |  |(Splinting)|
  +---------+---------------+--+-----------+--+---------------+--+-----------+--> Time

Operational Modes of Bilevel Therapy

Bilevel devices operate across three primary technical modes:

1. Spontaneous (S) Mode: The device relies entirely on patient effort. The patient's spontaneous inspiratory effort triggers the switch from EPAP to IPAP, and the patient's expiratory cycling shifts pressure back to EPAP. If the patient becomes apneic, the machine remains at EPAP.
2. Timed (T) Mode: The device cycles between IPAP and EPAP purely based on clinician-set respiratory rate (breaths per minute) and inspiratory time ($T_i$), independent of patient effort. Rarely used alone in outpatient care.
3. Spontaneous/Timed (S/T) Mode: The patient initiates breaths spontaneously, but a clinician-programmed Backup Respiratory Rate (BURR) acts as a safety floor. If the patient's spontaneous respiratory rate falls below the set rate (e.g., 12 breaths/min) or a central pause exceeds a timed interval (e.g., 5 seconds), the machine automatically delivers a machine-triggered, timed IPAP/EPAP cycle.

Primary Clinical Indications for Bilevel Therapy

• CPAP Intolerance: Patients unable to tolerate high continuous CPAP pressures (typically ≥15 cmH2O) due to difficulty exhaling against resistance, chest wall fatigue, or aerophagia.
• Sleep-Related Hypoventilation Syndromes: Obesity Hypoventilation Syndrome (OHS, daytime awake PaCO2 ≥45 mmHg), where elevated pressure support ($PS \ge 4$–8 cmH2O) is mandatory to augment alveolar ventilation.
• COPD-OSA Overlap Syndrome: To overcome intrinsic positive end-expiratory pressure (auto-PEEP) and reduce the metabolic work of breathing.
• Neuromuscular Diseases: Amyotrophic lateral sclerosis (ALS), muscular dystrophies, and diaphragm paralysis causing nocturnal hypercapnic ventilatory failure.

Adaptive Servo-Ventilation (ASV)

Adaptive Servo-Ventilation (ASV) is an advanced closed-loop, servomechanism-controlled bilevel modality specifically engineered to stabilize periodic, waxing-and-waning breathing patterns characteristic of Central Sleep Apnea (CSA) and Cheyne-Stokes Breathing (CSB).

Dynamic Servomechanism Function

ASV incorporates rapid-sampling digital flow sensors that continuously calculate a moving average of the patient's ventilation over the preceding 2 to 3 minutes. The device establishes a dynamic target minute ventilation (typically 90% of the patient's recent baseline):

• During Hyperpnea (Ventilatory Overshoot): As the patient hyperventilates, the algorithm recognizes that minute ventilation exceeds the target and reduces Pressure Support to its minimum setting (PS min, typically 0 to 3 cmH2O), preventing hypocapnia and subsequent respiratory pauses.
• During Hypopnea or Central Apnea (Ventilatory Undershoot): As ventilation drops below the 90% target, the algorithm rapidly ramps up Pressure Support (up to PS max, often 15 to 20 cmH2O) and delivers a timed backup respiratory rate, stabilizing minute ventilation and preventing oxygen desaturation.

SERVE-HF and Current Guidance

Later evidence refined the picture. ADVENT-HF (2024), using a different (peak-flow-targeted) ASV algorithm, found no mortality increase in heart failure with LVEF ≤45%. The AASM 2025 central sleep apnea guideline conditionally suggests ASV for several types of CSA, including CSA due to heart failure, but limits its use in reduced ejection fraction to experienced centers with close monitoring and shared decision-making.

AASM Clinical Practice Parameters for PAP Titration

The American Academy of Sleep Medicine (AASM) establishes standardized protocols for in-laboratory polysomnographic PAP titrations across adult populations:

Recommended Starting Pressures & Adjustment Increments

• CPAP: Recommended minimum starting pressure is 4 cmH2O. Pressure is increased by at least 1 cmH2O over an interval of not less than 5 minutes to control obstructive events.
• Bilevel PAP: Recommended starting pressures are IPAP 8 cmH2O and EPAP 4 cmH2O (minimum Pressure Support of 4 cmH2O). The maximum recommended IPAP is 30 cmH2O.
  • Increase both IPAP and EPAP by ≥1 cmH2O (no more often than every 5 minutes) if obstructive apneas persist.
  • Increase IPAP alone by ≥1 cmH2O if hypopneas, RERAs or snoring persist.
  • Maintain a minimum Pressure Support of 4 cmH2O and maximum Pressure Support of 10 cmH2O (unless treating hypoventilation).

AASM Titration Quality Grades (2008 Clinical Guideline)

• Optimal: RDI <5 per hour for at least 15 minutes at the selected pressure, including supine REM sleep not continually interrupted by arousals.
• Good: RDI ≤10 per hour, or reduced by 50% if the baseline RDI was under 15, including supine REM sleep not continually interrupted by arousals.
• Adequate: RDI not reduced to ≤10 but reduced by 75% from baseline (especially in severe OSA), or optimal or good criteria met except that supine REM sleep was not recorded at the selected pressure.
• Unacceptable: none of the above.

At the selected pressure, SpO2 should also stay above 90% with acceptable leak.

PAP Modalities Comparison Matrix